AI reads eye photos to spot Diabetes-Related vision loss

NCT ID NCT04699864

Terminated Diagnosis Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) Source: ClinicalTrials.gov ↗

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This study tests whether an artificial intelligence program called NeoRetina can accurately detect diabetic retinopathy and diabetic macular edema from simple eye photographs. Researchers will compare the AI's analysis to standard exams by eye doctors. The goal is to see if this AI can provide a fast, non-invasive screening option for people with diabetes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: NeoRetina artificial intelligence algorithm
What this could lead to: If accurate, this AI could help screen for diabetic eye disease quickly and without pupil dilation, making early detection more accessible.
What could go wrong: This is a small, early validation study (24 participants). The AI may not perform as well as a specialist exam, and results may not apply to broader populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates